EUVIMEDEUVIMED entdecken
Open Access

VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia—Brief Report

Michael D Donnan iD, Dilip K Deb, Vidhi Dalal iD, Valentin David iD, Daniele Procissi iD, Susan E Quaggin iD

Arteriosclerosis, Thrombosis, and Vascular Biology · 2025

DOI: 10.1161/atvbaha.124.319743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arteriosclerosis, Thrombosis, and Vascular Biology, 2025. Verfasst von Michael D Donnan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor C, Lymphangiogenesis, Disease Models, Animal, Lymphangiectasis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Lymphangiogenesis is believed to be a protective response in the setting of multiple forms of kidney injury and mitigates the progression of interstitial fibrosis. To augment this protective response, promoting kidney lymphangiogenesis is being investigated as a potential treatment to slow the progression of kidney disease. As injury-related lymphangiogenesis is driven by signaling from the receptor VEGFR3 (vascular endothelial growth factor receptor 3) in response to the cognate growth factor VEGF (vascular endothelial growth factor)-C released by tubular epithelial cells, this signaling pathway is a candidate for future kidney therapeutics. However, the consequences to kidney development and function to targeting this signaling pathway remain poorly defined. METHODS: We generated a new mouse model expressing Vegfc under regulation of the nephron progenitor Six2Cre driver strain ( Six2Vegfc ). Mice underwent a detailed phenotypic evaluation. Whole kidneys were processed for histology and 3-dimensional imaging. RESULTS: Six2Vegfc mice had reduced body weight and kidney function compared with littermate controls. Six2Vegfc kidneys demonstrated large peripelvic fluid-filled lesions with distortion of the pelvicalcyceal system which progressed in severity with age. Three-dimensional imaging showed a 3-fold increase in total cortical vascular density. Histology confirmed a substantial increase in LYVE1+ (lymphatic vessel endothelial hyaluronan receptor-1)/PDPN+ (podoplanin)/VEGFR3+ lymphatic capillaries extending alongside EMCN+ (endomucin) peritubular capillaries. There was no change in EMCN+ peritubular capillary density. CONCLUSIONS: Kidney lymphatic density was robustly increased in the Six2Vegfc mice. There were no changes in peritubular blood capillary density despite these endothelial cells also expressing VEGFR3. The model resulted in malformation of the lymphatic hilar plexus, resulting in severe hydronephrosis that resembled a human condition termed renal lymphangiectasia. This study defines the vascular consequences of augmenting VEGFC signaling during kidney development and provides new insight into human renal lymphatic malformations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor CLymphangiogenesisDisease Models, AnimalLymphangiectasisLymphatic VesselsAnimalsStem CellsMice, TransgenicKidneyMiceVascular Endothelial Growth Factor Receptor-3MaleSignal TransductionFemalePhenotypeMice, Inbred C57BL

Stichwörter der Autor:innen

kidneylymphatic vesselsmicevascular endothelial growth factor cvascular malformations

Substanzen

Vascular Endothelial Growth Factor Cvascular endothelial growth factor C, mouseVascular Endothelial Growth Factor Receptor-3

Autor:innen und Institutionen

  • Feinberg Cardiovascular and Renal Research Institute, Northwestern University Feinberg School of Medicine, Chicago, IL.

ORCID-Profile: Michael D Donnan, Vidhi Dalal, Valentin David, Daniele Procissi, Susan E Quaggin

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS

Zitieren

APA

Donnan, M. D., Deb, D. K., Dalal, V., David, V., Procissi, D., & Quaggin, S. E. (2025). VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/atvbaha.124.319743

Vancouver

Donnan MD, Deb DK, Dalal V, David V, Procissi D, Quaggin SE. VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia—Brief Report. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025. doi:10.1161/atvbaha.124.319743

BibTeX
@article{Donnan2025,
  author = {Donnan, Michael D and Deb, Dilip K and Dalal, Vidhi and David, Valentin and Procissi, Daniele and Quaggin, Susan E},
  title = {VEGFC Overexpression in Kidney Progenitor Cells Is a Model of Renal Lymphangiectasia—Brief Report},
  journal = {Arteriosclerosis, Thrombosis, and Vascular Biology},
  year = {2025},
  doi = {10.1161/atvbaha.124.319743}
}
Kostenlos starten →